socalTECH

MAY 8, 2012

The venture capital arm of Thousand Oaks-based Amgen has placed more funding into one of its portfolio companies, Sutro Biopharma , which is working on developing a scalable biochemical protein synthesis platform aimed at cancer therapeutics. Sutro said it has raised $16.5M

Thousand Oaks 140

Thousand Oaks Invest Venture Capital Platform 140

socalTECH

JANUARY 27, 2020

Kobe Bryant , the basketball legend who also was one half of Los Angeles private equity investment firm Bryant Stibel , is dead at the age of 41, after a tragic helicopter crash in Calabasas took his life, the life of one of his daughters, and seven others.

Thousand Oaks 113

Thousand Oaks Legalzoom Calabasas High Tech 113

socalTECH

OCTOBER 12, 2016

Thousand Oaks-based Akriveia Therapeutics , a biotechnology startup focused on immuno-oncology, announced this morning that it has raised $7.5M in a Series A investment. The investment came from F-Prime Capital Partners. As part of the funding, F-Prime's Thomas Beck and Ben Auspitz have joined the company's board.

Thousand Oaks 100

Thousand Oaks Research Activity Invest 100

socalTECH

DECEMBER 17, 2013

Thousand Oaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M in a Series B funding round, for its efforts to develop treatments for patients with end-stage renal disease.

Thousand Oaks 180

Thousand Oaks Venture Capital Capital Funding 180

socalTECH

JANUARY 10, 2014

Thousand Oaks-based Atara Biotherapeutics announced this morning that it is in a second close of its Series B funding round, bringing its total raised in the funding to $52M.

Thousand Oaks 147

Thousand Oaks Capital Funding Invest 147

socalTECH

JANUARY 22, 2010

invested in Southern California in Q4. was invested in Southern California, as well as Q4 of last year, when $508.2M was invested in the region. However, nationally, venture capital numbers were much worse, with venture investments dropping to the lowest level in more than a decade. in investments. in investments.

Southern California 154

Southern California Venture Capital Invest Orange County 154

socalTECH

OCTOBER 22, 2015

Thousand Oaks-based Amgen , via its nonprofit arm, The Amgen Foundation , said Wednesday that it will spend more than $4M to help bring hands on biotechnology labs to schools. Amgen said that it has invested a total of more than $13 million since it launched the Amgen Biotech Experience in 1990. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Funding Invest Help 100

socalTECH

DECEMBER 17, 2010

Thousand Oaks-based Amgen , via its nonprofit foundation, the Amgen Foundation, said Friday that it is giving $1.8M According to the two, the funding will go towards increasing the number of math and science graduates who are joining Teach For America's teaching corps by 2013. to the Teach For America effort. READ MORE>>.

Thousand Oaks 209

Thousand Oaks Invest Funding Help 209

socalTECH

OCTOBER 9, 2015

Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. Adheron said that it has been acquired by Roche , in a deal worth $105M upfront and up to $475M in additional milestone payments.

Thousand Oaks 100

Thousand Oaks Venture Capital Activity Capital 100

socalTECH

JANUARY 22, 2010

invested in Southern California in Q4. was invested in Southern California, as well as Q4 of last year, when $508.2M was invested in the region. However, nationally, venture capital numbers were much worse, with venture investments dropping to the lowest level in more than a decade. in investments. in investments.

Southern California 113

Southern California Invest Venture Capital Orange County 113

socalTECH

APRIL 8, 2014

Thousand Oaks-based drug development company Atara Biotherapeutics announced this morning that it has added Matthew K. Fust as a board member, and hired Mitchall G. Clark as its Chief Regulatory and Quality Assurance Officer. READ MORE>>. atara biotherapeutics renal disease lifescience amgen executive board'

Thousand Oaks 138

Thousand Oaks Invest Capital Funding 138

socalTECH

OCTOBER 29, 2015

in a funding round. I grew up in Thousand Oaks, went to USC, and we met each other way back in the 90's. Where there are lots of players focused on different types of equity, different types of investments, different types of debt, they're doing it in a very unfocused manner. There's lot of great stuff happening here.

Southern California 100

Southern California Google Technical Review Manhattan Beach 100

Xconomy

JULY 22, 2016

It’s the first partnership for Jounce, and a big one: the startup got a $225 million up front cash payment from Celgene and a $36 million equity investment. And in other Amgen news, the Thousand Oaks, CA, company filed for FDA approval of osteoporosis drug romosuzumab.

Startup 40

Startup San Diego News Thousand Oaks 40

Xconomy

AUGUST 26, 2016

—Amgen (NASDAQ: AMGN ) of Thousand Oaks, CA, said that the FDA rejected its drug etelcalcetide (Parasbiv) , a treatment for patients with an excess of damaging hormone release because of chronic kidney disease. . —A five-day workshop in Washington, D.C., Morgan party.

Pricing 40

Pricing Thousand Oaks Startup Research 40

SoCal Delicious

APRIL 5, 2010

• Jack Gilbert , once the chief executive officer of a large Los Angeles-based corporation, later founded Thousand Oaks Land Development and played a major role in the development of Thousand Oaks area, leading that city’s emergence as a major business and corporate center.

Santa Barbara 53

Santa Barbara Thousand Oaks Oracle Ventura 53